Literature DB >> 8335018

Relationship between café-au-lait spots as the only symptom and peripheral neurofibromatosis (NF1): a follow-up study.

A Fois1, L Calistri, P Balestri, R Vivarelli, G Bartalini, L Mancini, A Berardi, M Vanni.   

Abstract

We re-examined 21 children with the possible diagnosis of peripheral neurofibromatosis (NF1) based on the presence of café-au-lait (CAL) spots as the single clinical finding. We evaluated whether "typical" or "atypical" appearance of the spots was important for the final diagnosis and whether the co-existence of other non-specific signs (e.g. pectus excavatum) were of any significance for the final diagnosis. In 8/14 (57.1%) cases with "typical" CAL spots, the diagnosis of NF1 was finally established on the basis of other criteria. For the other 6 patients the diagnosis is not yet definitive but highly probable on the basis of the presence of macrocephaly, pectus excavatum and/or MRI findings. Only one patient among five with "atypical" CAL spots possibly has NF1.

Entities:  

Mesh:

Year:  1993        PMID: 8335018     DOI: 10.1007/bf01955059

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

1.  Macromelanosomes in the early diagnosis of neurofibromatosis.

Authors:  C Slater; M Hayes; N Saxe; C Temple-Camp; P Beighton
Journal:  Am J Dermatopathol       Date:  1986-08       Impact factor: 1.533

2.  A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.

Authors:  R M Cawthon; R Weiss; G F Xu; D Viskochil; M Culver; J Stevens; M Robertson; D Dunn; R Gesteland; P O'Connell
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

3.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

4.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

Review 5.  Von Recklinghausen neurofibromatosis.

Authors:  V M Riccardi
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

6.  Neurofibromatosis types 1 and 2: cranial MR findings.

Authors:  S Aoki; A J Barkovich; K Nishimura; B O Kjos; T Machida; P Cogen; M Edwards; D Norman
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

7.  cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.

Authors:  D A Marchuk; A M Saulino; R Tavakkol; M Swaroop; M R Wallace; L B Andersen; A L Mitchell; D H Gutmann; M Boguski; F S Collins
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

8.  The significance of MRI abnormalities in children with neurofibromatosis.

Authors:  P K Duffner; M E Cohen; F G Seidel; D W Shucard
Journal:  Neurology       Date:  1989-03       Impact factor: 9.910

9.  Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata.

Authors:  R A Lewis; V M Riccardi
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

10.  Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study.

Authors:  R L Martuza; I Philippe; T B Fitzpatrick; J Zwaan; Y Seki; J Lederman
Journal:  J Invest Dermatol       Date:  1985-10       Impact factor: 8.551

View more
  3 in total

1.  Surgical treatment of giant plexiform neurofibroma associated with pectus excavatum.

Authors:  Yi Ji; Bing Xu; Xuejun Wang; Wenying Liu; Siyuan Chen
Journal:  J Cardiothorac Surg       Date:  2011-09-28       Impact factor: 1.637

2.  GNA11 Mutation as a Cause of Sturge-Weber Syndrome: Expansion of the Phenotypic Spectrum of Gα/11 Mosaicism and the Associated Clinical Diagnoses.

Authors:  Satyamaanasa Polubothu; Lara Al-Olabi; Maria Carmen Del Boente; Alisha Chacko; Georgios Eleftheriou; Mary Glover; David Jiménez-Gallo; Elizabeth A Jones; Debra Lomas; Regina Fölster-Holst; Samira Syed; Monika Tasani; Anna Thomas; Martin Tisdall; Antonio Torrelo; Sarah Aylett; Veronica A Kinsler
Journal:  J Invest Dermatol       Date:  2019-12-12       Impact factor: 8.551

Review 3.  Neurofibromatosis type 1 in genetic counseling practice: recommendations of the National Society of Genetic Counselors.

Authors:  Heather B Radtke; Courtney D Sebold; Caroline Allison; Joy Larsen Haidle; Gretchen Schneider
Journal:  J Genet Couns       Date:  2007-07-17       Impact factor: 2.537

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.